G8166
Glucagon-Like Peptide 2 -Arg human trifluoroacetate salt
>90% (HPLC), solid
Sinónimos:
GLP-2-Arg, Preproglucagon 126-159
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| Tamaño de envase | SKU | Disponibilidad | Precio |
|---|---|---|---|
| 0.5 mg | Comprobar disponibilidad del carrito | US$ 731,00 |
Acerca de este artículo
Fórmula empírica (notación de Hill):
C171H266N48O56S
Número CAS:
Peso molecular:
3922.29
UNSPSC Code:
51111800
NACRES:
NA.32
MDL number:
US$ 731,00
PRECIOS SIN IMPUESTOS NACIONALES
Comprobar disponibilidad del carrito
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleGeneral description
Application
Glucagon-Like Peptide 2 (GLP-2) -Arg human trifluoroacetate salt has been used for injection in chickens to determine the effects of GLP-2 on the weight and morphology of small intestines.[1]
Biochem/physiol Actions
Glucagon-like peptide 2 (GLP-2) influences the functionality of gastrointestinal tract by participating in the feedback loop to the brain for the control of food intake. It also controls digestion and absorption, and has tropic effects post chemotherapy injury or surgical resection.[1] This peptide is also responsible for epithelial cell proliferation of the small bowel.[3] Studies in rats show that this peptide enhances the effects of the ileal-brake hormones, GLP-1 and peptide YY. It also negatively regulates gastrointestinal motility and secretion. Thus, it has potential as a therapeutic agent in short-bowel syndrome.[2]
Glucagon-like peptide 2 is a neuropeptide that inhibits food intake when injected into the lateral ventricles of the brain and may mediate satiety. It is also a growth factor that stimulates proliferation and blocks apoptosis of intestinal epithelial cells.
Neuropeptide that inhibits food intake when injected into the lateral ventricles of the brain and may mediate satiety; also a growth factor that stimulates proliferation and blocks apoptosis of intestinal epithelial cells.
1 of 1
Este artículo | |||
|---|---|---|---|
| assay >90% (HPLC) | assay ≥97% (HPLC) | assay ≥97% (HPLC) | assay ≥95% (HPLC) |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 300 |
| form solid | form - | form powder | form powder |
| Gene Information human ... GCG(2641) | Gene Information human ... GCG(2641) | Gene Information human ... GCG(2641) | Gene Information human ... GCG(2641) |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
P B Jeppesen et al.
Gastroenterology, 120(4), 806-815 (2001-03-07)
Glucagon-like peptide 2 (GLP-2) is intestinotrophic, antisecretory, and transit-modulating in rodents, and it is mainly secreted from the intestinal mucosa of the terminal ileum and colon after food ingestion. We assessed the effect of GLP-2 on the gastrointestinal function in
X F Hu et al.
Poultry science, 89(9), 1967-1974 (2010-08-17)
An experiment was conducted to determine the effect of injecting glucagon-like peptide 2 (GLP-2) on the small intestinal weight, morphology, and nutrient transporter expression in pharmacologically stressed broiler chickens. A total of 144 seven-day-old birds were fed either a basal
D J Drucker et al.
Proceedings of the National Academy of Sciences of the United States of America, 93(15), 7911-7916 (1996-07-23)
Injury, inflammation, or resection of the small intestine results in severe compromise of intestinal function. Nevertheless, therapeutic strategies for enhancing growth and repair of the intestinal mucosal epithelium are currently not available. We demonstrate that nude mice bearing subcutaneous proglucagon-producing
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| G8166-.5MG | 04061832820552 |